Cover Image

Advances in binding kinetics and mechanistic PK/PD modelling

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Bharath Srinivasan
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics
by: Bharath Srinivasan
Published: (2025)

Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
by: Hongtao Yu, et al.
Published: (2025)

Antiviral activity, safety and PK/PD of ACC017 in antiretroviral naïve HIV‐infected adults: A randomized, double‐blind, placebo/dose‐parallel‐controlled short‐term monotherapy study
by: N. Han, et al.
Published: (2025)

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration
by: Sivakumar Srinivasan, et al.
Published: (2025)

Elucidation of the zinc binding site in KCNQ channels
by: Shuo Zhang, et al.
Published: (2025)

A comment on the interpretation of ligand binding experiments for agonists
by: James P. Higham
Published: (2025)

Time‐varying compartmental models capture hours‐scale variation in the elimination kinetics of vancomycin in rats
by: Matthew H. McDonough, et al.
Published: (2025)

Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application
by: Kanika Thakur, et al.
Published: (2024)

The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19
by: Henrietta Papp, et al.
Published: (2024)

Cabotegravir PopPK analysis of adults and adolescents living with HIV/at risk for HIV receiving prep
Published: (2024)

Only time will tell: Modelling the kinetics of covalent inhibitors
by: Madeeha I. Ali, et al.
Published: (2026)

STRATIfy‐PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti‐TNF–treated patient
by: Carles Iniesta‐Navalón, et al.
Published: (2025)

Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
by: Yen‐Wen Wu, et al.
Published: (2025)

Flecainide binding dynamics in voltage‐gated sodium channels: A comparative isoform analysis of the state‐dependent block
by: Tatsuo Munakata, et al.
Published: (2026)

A mitochondria‐targeting and G‐quadruplex structure‐binding ligand inducing calcium overload and ferroptosis in human cancer cells
by: Bo‐Xin Zheng, et al.
Published: (2025)

α‐Linolenic acid suppresses Th17 cell differentiation to mitigate allergic rhinitis by binding to Lyn kinase in mast cells
by: Yuejin Wang, et al.
Published: (2026)

Dimerisation of the VIP receptor VIPR2 is essential to its binding VIP and Gαi proteins, and to its functions in breast cancer cells
by: Satoshi Asano, et al.
Published: (2025)

Population kinetic/pharmacodynamic modelling of the haemodynamic effects of cafedrine/theodrenaline (Akrinor) under general anaesthesia
by: Christiane Dings, et al.
Published: (2024)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
by: Geoffrey Canet, et al.
Published: (2025)

Changes in the plasma protein‐binding rate of remifentanil during cardiopulmonary bypass
by: Hiroshi Ueda, et al.
Published: (2024)

Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways
by: Xiao Chen, et al.
Published: (2024)

Inhibition of the calcineurin/forkhead box O1/fatty acid binding protein 4 pathway prevents SERCA2 dysfunction‐induced foam cell formation and atherosclerosis
by: Beibei Zhu, et al.
Published: (2025)

Advancing antihypertensive drug development
by: Fay Pu, et al.
Published: (2025)

Variable temocillin protein binding and pharmacokinetics in different clinical conditions: Implications for target attainment
by: Letao Li, et al.
Published: (2025)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
by: Rao Hu, et al.
Published: (2026)

Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39
by: Kira Devantier, et al.
Published: (2024)

Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer's disease: A preclinical study in zebrafish
by: Balasubramanian Haridevamuthu, et al.
Published: (2024)

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
by: Laith Alexander, et al.
Published: (2024)

Have plastic culture models prevented the discovery of effective cancer therapeutics?
by: Kevin M. Tharp
Published: (2024)

System level network data and models attack cancer drug resistance
by: Márk Kerestély, et al.
Published: (2025)

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
by: Thi Viet Ha Nguyen, et al.
Published: (2025)

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
by: Elisa Kiselev, et al.
Published: (2025)

Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis
by: Guendalina Olivero, et al.
Published: (2024)

TRPA1 up‐regulation mediates oxidative stress in a pulpitis model in vitro
by: Árpád Kunka, et al.
Published: (2024)

The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial
by: Hongtao Yu, et al.
Published: (2024)

Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach
by: Balasubramanian Haridevamuthu, et al.
Published: (2024)

A deep neural network model for optimizing traditional Chinese medicine prescriptions with data augmentation
by: Xiaohan Mao, et al.
Published: (2025)

β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia
by: Alessandro Pini, et al.
Published: (2026)

C‐model: A comprehensive enhanced pharmacokinetic/pharmacodynamic simulation environment targeting the complement system
by: Lucía Alfonso‐González, et al.
Published: (2025)

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation
by: Claudius E. Degro, et al.
Published: (2024)